InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,604.00
(
1.06%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.37
(
0.29%
)
Bitcoin
63,464.78
(
-0.83%
)
Post# of 298
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Penny Roger$

Send PM Follow Ignore
Followers 1106
Posts 279775
Boards Moderated 10
Alias Born 03/18/2011

Penny Roger$

Re: None

Friday, 10/24/2014 11:17:22 AM

Friday, October 24, 2014 11:17:22 AM

Post# of 298
AstraZeneca ovarian cancer drug wins European green light
[Reuters] - AstraZeneca's cancer drug pipeline received a boost on Friday as European regulators recommended approval of an experimental medicine against ovarian cancer. The green light from the European Medicines Agency (EMA) for olaparib, or Lynparza, is welcome news since the product hit a road bump in June when a U.S. AstraZeneca has flagged the medicine as a potential $2 billion-a-year seller. The EMA said its committee of experts on new drugs also recommended approval of Pfizer's Duavive for oestrogen deficiency, Baxter International's Rixubis for haemophilia and Clinuvel's Scenesse for phototoxicity.
Today 06:11 AM

http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/astrazeneca-ovarian-cancer-drug-wins-111100010.html

Do your DD! Spend only the money you can afford to lose, while still willing to play at other tables. Commissions are cheaper than losses!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AZN News
More AZN News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!